申请人:Goodnow, Alan Robert
公开号:US20060063814A1
公开(公告)日:2006-03-23
The present invention relates to compounds of the formula
which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
本发明涉及以下公式的化合物,这些化合物在治疗以MEK高活性为特征的疾病方面具有用途。因此,这些化合物在治疗癌症、认知和中枢神经系统疾病以及炎症/自身免疫疾病等疾病方面具有用途。